Certified by Founder
Lodge
Asimov
start up
United States
- Boston, Massachusetts
- 07/02/2023
- Series B
- $200,000,000
Asimov builds tools to program living cells. By integrating mammalian synthetic biology, computer-aided design, and machine learning, our multi-disciplinary team is advancing the design and manufacture of biologics and gene therapies.
- Industry Biotechnology Research
- Website https://www.asimov.com/
- LinkedIn https://www.linkedin.com/company/asimov/about/
Beacon Software | $250,000,000 | (Nov 5, 2025)
Downstream | $8,000,000 | (Nov 5, 2025)
Ruli | $6,000,000 | (Nov 5, 2025)
Mine Vision Systems | $12,500,000 | (Nov 5, 2025)
Planbase (YC S24) | $2,100,000 | (Nov 5, 2025)
The EVERY Company | $55,000,000 | (Nov 5, 2025)
Daylight Security | $33,000,000 | (Nov 5, 2025)
Azalea Therapeutics | $82,000,000 | (Nov 5, 2025)
Parable | $11,000,000 | (Nov 5, 2025)
Sunflower Labs | $16,000,000 | (Nov 5, 2025)
C.Scale | $2,000,000 | (Nov 5, 2025)
Portal26 | $9,000,000 | (Nov 5, 2025)